Merck stole the show at the European Society for Medical Oncology (ESMO) annual conference, with new data on its ...
Ilya Yuffa will take on an expanded role as executive vice president and president, Lilly Global Markets, overseeing customer ...
Medical Component Specialists (MCS), a leading provider of medical components, proudly announces the appointment of Pedro ...
The largest pharmas have a collective $188 billion in firepower to spend on M&A transactions, with all but one signaling a ...
A clearly superior clinical profile, reasonable pricing and easy access has helped a handful of recently approved therapies ...
Three former employees of large pharmas, including Novo and Sanofi, share how they were let go. While they appreciated some ...
Drug developers increasingly have the option of seeking regulatory approval and commercializing a medicine themselves, rather ...
Kaye/Bassman’s Michael Pietrack explores the guilt and grief executives feel when their direct reports are downsized and ...
Company to host an in-person and virtual Investor Day on November 12, 2026. BOSTON, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Praxis ...
Châtillon, France, October 27, 2026. DBV Technologies to Report Third Quarter 2026 Financial Results and Business Update on ...
Rumi Therapeutics, a drug-development company within Rumi Scientific Holdings, today announced an option to license agreement ...
Dr. Prat to lead session on global sourcing, pipeline resource allocation, regulatory alignment, and responsible AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results